2. As of noon trading, Covidien ( COV) is down $0.23 (-0.4%) to $57.88 on average volume Thus far, 920,178 shares of Covidien exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $57.53-$58.38 after having opened the day at $58.18 as compared to the previous trading day's close of $58.11. Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $27.6 billion and is part of the health services industry. The company has a P/E ratio of 14.8, below the S&P 500 P/E ratio of 17.7. Shares are up 29.3% year to date as of the close of trading on Friday. Currently there are 13 analysts that rate Covidien a buy, 1 analyst rates it a sell, and 2 rate it a hold. TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, reasonable valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Covidien Ratings Report now. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Community Health Systems may close its $7.6 billion acquisition of Health Management Associates, but with the uncertainties of a new healthcare law and the merger partners' own legal problems, it needed good timing to put reasonable financing in place.